These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37216922)

  • 21. The Association of Prior Intensive Lifestyle Intervention and Diabetes Support and Education With Frailty Prevalence at Long-Term Follow-Up in the Action for Health in Diabetes Extension Study.
    Look AHEAD Research Group
    J Gerontol A Biol Sci Med Sci; 2022 Oct; 77(10):2040-2049. PubMed ID: 34637524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of liraglutide on visceral and ectopic fat in adults with overweight and obesity at high cardiovascular risk: a randomised, double-blind, placebo-controlled, clinical trial.
    Neeland IJ; Marso SP; Ayers CR; Lewis B; Oslica R; Francis W; Rodder S; Pandey A; Joshi PH
    Lancet Diabetes Endocrinol; 2021 Sep; 9(9):595-605. PubMed ID: 34358471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low-carbohydrate versus balanced-carbohydrate diets for reducing weight and cardiovascular risk.
    Naude CE; Brand A; Schoonees A; Nguyen KA; Chaplin M; Volmink J
    Cochrane Database Syst Rev; 2022 Jan; 1(1):CD013334. PubMed ID: 35088407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Change in Cardiometabolic Risk Factors Associated With Magnitude of Weight Regain 3 Years After a 1-Year Intensive Lifestyle Intervention in Type 2 Diabetes Mellitus: The Look AHEAD Trial.
    Berger SE; Huggins GS; McCaffery JM; Jacques PF; Lichtenstein AH
    J Am Heart Assoc; 2019 Oct; 8(20):e010951. PubMed ID: 31594431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Binge eating and weight loss outcomes in overweight and obese individuals with type 2 diabetes: results from the Look AHEAD trial.
    Gorin AA; Niemeier HM; Hogan P; Coday M; Davis C; DiLillo VG; Gluck ME; Wadden TA; West DS; Williamson D; Yanovski SZ;
    Arch Gen Psychiatry; 2008 Dec; 65(12):1447-55. PubMed ID: 19047532
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes.
    Wing RR; Lang W; Wadden TA; Safford M; Knowler WC; Bertoni AG; Hill JO; Brancati FL; Peters A; Wagenknecht L;
    Diabetes Care; 2011 Jul; 34(7):1481-6. PubMed ID: 21593294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Obesity and weight loss are inversely related to mortality and cardiovascular outcome in prediabetes and type 2 diabetes: data from the ORIGIN trial.
    Doehner W; Gerstein HC; Ried J; Jung H; Asbrand C; Hess S; Anker SD
    Eur Heart J; 2020 Jul; 41(28):2668-2677. PubMed ID: 32402060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of Weight Loss Maintenance and Weight Regain on 4-Year Changes in CVD Risk Factors: the Action for Health in Diabetes (Look AHEAD) Clinical Trial.
    Wing RR; Espeland MA; Clark JM; Hazuda HP; Knowler WC; Pownall HJ; Unick J; Wadden T; Wagenknecht L;
    Diabetes Care; 2016 Aug; 39(8):1345-55. PubMed ID: 27271190
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of a long-term lifestyle modification programme on peripheral neuropathy in overweight or obese adults with type 2 diabetes: the Look AHEAD study.
    Look AHEAD Research Group
    Diabetologia; 2017 Jun; 60(6):980-988. PubMed ID: 28349174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intentional Weight Loss and Longevity in Overweight Patients with Type 2 Diabetes: A Population-Based Cohort Study.
    Køster-Rasmussen R; Simonsen MK; Siersma V; Henriksen JE; Heitmann BL; de Fine Olivarius N
    PLoS One; 2016; 11(1):e0146889. PubMed ID: 26808532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of visceral adipose tissue reduction on CVD risk factors independent of weight loss: The Look AHEAD study.
    Sanguankeo A; Lazo M; Upala S; Brancati FL; Bonekamp S; Pownall HJ; Balasubramanyam A; Clark JM;
    Endocr Res; 2017 May; 42(2):86-95. PubMed ID: 27351077
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of Lifestyle Intervention With Risk for Cardiovascular Events Differs by Level of Glycated Hemoglobin.
    Bancks MP; Pilla SJ; Balasubramanyam A; Yeh HC; Johnson KC; Rigdon J; Wagenknecht LE; Espeland MA
    J Clin Endocrinol Metab; 2024 Feb; 109(3):e1012-e1019. PubMed ID: 37978826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overweight and obesity and weight change in middle aged men: impact on cardiovascular disease and diabetes.
    Wannamethee SG; Shaper AG; Walker M
    J Epidemiol Community Health; 2005 Feb; 59(2):134-9. PubMed ID: 15650145
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suboptimal control of glycemia, blood pressure, and LDL cholesterol in overweight adults with diabetes: the Look AHEAD Study.
    Bertoni AG; Clark JM; Feeney P; Yanovski SZ; Bantle J; Montgomery B; Safford MM; Herman WH; Haffner S;
    J Diabetes Complications; 2008; 22(1):1-9. PubMed ID: 18191071
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in body weight and blood pressure: paradoxical outcome events in overweight and obese subjects with cardiovascular disease.
    Seimon RV; Espinoza D; Ivers L; Gebski V; Finer N; Legler UF; Sharma AM; James WP; Coutinho W; Caterson ID
    Int J Obes (Lond); 2014 Sep; 38(9):1165-71. PubMed ID: 24406481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of a Lifestyle Intervention Program With Energy-Restricted Mediterranean Diet and Exercise on Weight Loss and Cardiovascular Risk Factors: One-Year Results of the PREDIMED-Plus Trial.
    Salas-Salvadó J; Díaz-López A; Ruiz-Canela M; Basora J; Fitó M; Corella D; Serra-Majem L; Wärnberg J; Romaguera D; Estruch R; Vidal J; Martínez JA; Arós F; Vázquez C; Ros E; Vioque J; López-Miranda J; Bueno-Cavanillas A; Tur JA; Tinahones FJ; Martín V; Lapetra J; Pintó X; Daimiel L; Delgado-Rodríguez M; Matía P; Gómez-Gracia E; Díez-Espino J; Babio N; Castañer O; Sorlí JV; Fiol M; Zulet MÁ; Bulló M; Goday A; Martínez-González MÁ;
    Diabetes Care; 2019 May; 42(5):777-788. PubMed ID: 30389673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk of cardiovascular disease and mortality in overweight and obese patients with type 2 diabetes: an observational study in 13,087 patients.
    Eeg-Olofsson K; Cederholm J; Nilsson PM; Zethelius B; Nunez L; Gudbjörnsdóttir S; Eliasson B
    Diabetologia; 2009 Jan; 52(1):65-73. PubMed ID: 18985314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overweight in early adulthood, adult weight change, and risk of type 2 diabetes, cardiovascular diseases, and certain cancers in men: a cohort study.
    de Mutsert R; Sun Q; Willett WC; Hu FB; van Dam RM
    Am J Epidemiol; 2014 Jun; 179(11):1353-65. PubMed ID: 24786797
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of diet-induced weight loss on circulating homocysteine levels in people with obesity and type 2 diabetes.
    Al Fatly M; Mulder MT; Roeters van Lennep J; Blom HJ; Berk KAC
    Nutr J; 2024 Jan; 23(1):2. PubMed ID: 38167024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The importance of weight management in type 2 diabetes mellitus.
    Wilding JP
    Int J Clin Pract; 2014 Jun; 68(6):682-91. PubMed ID: 24548654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.